Source: Eur Respir J, 56 (2) 1902320; 10.1183/13993003.02320-2019



Rating:

Share or cite this content

Citations should be made in the following way:
Reinoud Gosens, Pieter S. Hiemstra, Ian M. Adcock, Ken R. Bracke, Robert P. Dickson, Philip M. Hansbro, Susanne Krauss-Etschmann, Hermelijn H. Smits, Frank R.M. Stassen, Sabine Bartel. Host–microbe cross-talk in the lung microenvironment: implications for understanding and treating chronic lung disease. Eur Respir J, 56 (2) 1902320; 10.1183/13993003.02320-2019

Member's Comments

No comment yet.

Related content which might interest you: The lung microbiome in obstructive airways disease: potential pathogenetic roles Source: Eur Respir Monogr 2019; 83: 140-157 Year: 2019 Cellular interactions in the pathogenesis of interstitial lung diseases Source: Eur Respir Rev 2015; 24: 102-114 Year: 2015 Determinants of lung cancer evolution: immune escape and inflammation Source: International Congress 2018 – Scientific Year in Review Year: 2018 Targeting EGFR signalling in chronic lung disease: therapeutic challenges and opportunities Source: Eur Respir J 2014; 44: 513-522 Year: 2014 Human rhinovirus 16 infection of human macrophages significantly impairs their phagocytic and regulatory functions: implications in understanding chronic inflammatory lung disease Source: International Congress 2017 – New Mechanistic Findings in COPD Year: 2017 The environment, epigenetics and lung disease Source: Annual Congress 2013 –PG6 Epigenetics of asthma and COPD Year: 2013 The consequences of microbiome and pathogen dynamics for chronic lung diseases Source: Annual Congress 2012 - The bacterial microbiota: implications for health and disease - joint session with the World Allergy Organisation Year: 2012 Cellular mechanisms of paediatric lung disease Source: Virtual Congress 2020 – Paediatric year in review Year: 2020 Interplay between bacterial infections, hypoxia and the development of chronic lung diseases Source: Annual Congress 2009 - Mechanisms of infection: what's new? Year: 2009 Neutrophil extracellular traps in chronic lung disease: implications for pathogenesis and therapy Source: Eur Respir Rev, 31 (163) 210241; 10.1183/16000617.0241-2021 Year: 2022 Revisiting the role of pulmonary surfactant in chronic inflammatory lung diseases and environmental exposure Source: Eur Respir Rev, 30 (162) 210077; 10.1183/16000617.0077-2021 Year: 2021 Host–microbe interactions in distal airways: relevance to chronic airway diseases Source: Eur Respir Rev 2015; 24: 78-91 Year: 2015 Local immune protection mechanisms during bacterial infection of the airways in patients with interstitial lung diseases Source: Annual Congress 2009 - Mechanisms of infection: what's new? Year: 2009 Crosstalk between lung fibroblasts and T-lymphocytes: Implications for anti-viral responses in chronic lung disease Source: Annual Congress 2013 –Asthma: new mechanisms and markers Year: 2013 Angiogenesis in lung development, injury and repair: implications for chronic lung disease of prematurity Source: Annual Congress 2008 - Physiological year in review Year: 2008 Influenza virus-induced lung injury: pathogenesis and implications for treatment Source: Eur Respir J 2015; 45: 1463-1478 Year: 2015 Host-microbe interactions: implications for protective immunity in the lung Source: Lung Science Conference 2015 Year: 2015 Signalling and transcriptional regulation in inflammatory and immune cells: importance in lung biology and disease Source: Eur Respir J 2005; 26: 762-763 Year: 2005 Current concepts: host–pathogen interactions in cystic fibrosis airways disease Source: Eur Respir Rev 2014; 23: 320-332 Year: 2014